Zobrazeno 1 - 10
of 177
pro vyhledávání: '"programmed death receptor 1"'
Publikováno v:
Zhongguo linchuang yanjiu, Vol 37, Iss 5, Pp 756-759 (2024)
Objective To compare the efficacy and safety of programmed cell death protein 1 (PD-1) inhibitor + albumin paclitaxel and platinum + PD-1 inhibitor + albumin-paclitaxel in the treatment of advanced metastasis or recurrent cervical cancer. Methods The
Externí odkaz:
https://doaj.org/article/18a0d6764a0a4a9f90a5f2313f580d91
Autor:
Haiyan Shan, Guangrong Zheng, Shasha Bao, Haiyan Yang, Ujen Duwal Shrestha, Guochen Li, Xirui Duan, Xiaolan Du, Tengfei Ke, Chengde Liao
Publikováno v:
Translational Oncology, Vol 49, Iss , Pp 102115- (2024)
Objective: To demonstrate the feasibility of using focused ultrasound to enhance delivery of PD-1 inhibitors in glioma rats and determine if such an approach increases treatment efficacy. Methods: C6 glioma in situ rat model was used in this study. T
Externí odkaz:
https://doaj.org/article/f7bba7c1e3a84a918137877645fd3b52
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-23 (2024)
Abstract Hepatocellular carcinoma (HCC) is a major health concern worldwide, with limited therapeutic options and poor prognosis. In recent years, immunotherapies such as immune checkpoint inhibitors (ICIs) have made great progress in the systemic tr
Externí odkaz:
https://doaj.org/article/71b3951101c047dbb0dc7a737cd5954a
Publikováno v:
Guoji laonian yixue zazhi, Vol 45, Iss 02, Pp 187-192 (2024)
Objective To explore the clinical efficacy of a programmed death receptor 1(PD-1) inhibitor in combination with amilorotinib in the treatment of elderly advanced non-small cell lung cancer(NSCLC) that has failed second-line chemotherapy. Methods A to
Externí odkaz:
https://doaj.org/article/5484d47287cc466a938e22bffd7d546a
Publikováno v:
Zhongguo quanke yixue, Vol 26, Iss 17, Pp 2095-2101 (2023)
Background Immunotherapy-related endocrine adverse reactions are relatively common, which often lead to serious outcomes if not treated in time. However, the incidence of immunotherapy-related endocrine adverse reactions varies widely in previous lit
Externí odkaz:
https://doaj.org/article/ec93403574904af4b5ded816288ef473
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marco Greppi, Valentina Obino, Rayan Goda, Federico Rebaudi, Simona Carlomagno, Mariella Della Chiesa, Simona Sivori, Gianluca Ubezio, Vanessa Agostini, Alessandra Bo, Silvia Pesce, Emanuela Marcenaro
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundNatural Killer cells (NKs) represent the innate counterpart of TCRαβ lymphocytes and are characterized by a high anti-tumor and an anti-viral cytotoxic activity. Recently, it has been demonstrated that NKs can express PD-1 as an additiona
Externí odkaz:
https://doaj.org/article/35381310a82a496a985bad68cfcad4ee
Publikováno v:
口腔疾病防治, Vol 29, Iss 10, Pp 706-710 (2021)
Head and neck squamous cell carcinoma (HNSCC) is a common malignant tumor that seriously threatens human health and life. With increasing studies on the mechanism of tumor immune escape, programmed death receptor 1 (PD-1) and programmed death ligand
Externí odkaz:
https://doaj.org/article/4b84097eba984f99a944a7fbd1a0fea3
Autor:
Ling JIANG, Zhiyi LIN, Na LI, Jinfang JIANG, Cengceng LU, Shenghang DU, Jun ZHANG, Yuanyuan WANG, Jun CHEN, Ping GONG
Publikováno v:
Chinese Journal of Lung Cancer, Vol 24, Iss 9, Pp 623-631 (2021)
Background and objective The treatment mode of lung cancer is epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) as a first-line treatment for patients with EGFR mutant in non-small cell lung cancer (NSCLC). At the same time prog
Externí odkaz:
https://doaj.org/article/5aeb5f855edd4f04b5f137df9b83e308
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.